PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



2534 MD Anderson Cancer Center Madrid Pathology Meeting program .pdf


Original filename: 2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program.pdf
Title: programa_triptico_variación.ai
Author: Hector_Alonso

This PDF 1.5 document has been generated by PScript5.dll Version 5.2.2 / Acrobat Distiller 11.0 (Windows), and has been sent on pdf-archive.com on 18/06/2018 at 13:19, from IP address 92.253.x.x. The current document download page has been viewed 292 times.
File size: 572 KB (2 pages).
Privacy: public file




Download original PDF file









Document preview


Sponsors

Target audience
The meeting is aimed at pathologists-in-training, molecular biologists,
and medical and surgical oncologists and surgeons.

Under the auspices of

PATHOLOGY MEETING
ADVANCES IN
PATHOLOGY
AND
MOLECULAR DIAGNOSTICS
in the E
Era of Personalized Cancer Therap
py

Accreditation
Continuing Education Credits requested to the Spanish National Health System
With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid

Certification

Madriid, October 5-7, 2016
Meeting Directors
Dr. Joseph Khoury
Dr. Juan Fernando García García

Venue
Mutua Madrileña Auditorium
Paseo de la Castellana, 33.
Madrid, Spain

Meeting secretariat

Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, Spain
Tel.: +34 91 372 0203 · E-mail: pathologymeeting@doctaforum.com
Registrations: www.mdanderson.es/pathologymeeting

@MDAnderson_ES

Wednesday, October 5th, 2016

11:45 - 13:30 Session 4: Breast cancer
Moderator:

13:00 - 14:00 Registration

Friday, October 7th, 2016

Dr. W. Frayser Symmans, The University of Texas MD Anderson Cancer Center. Houston, USA

11:45 - 12:15 Genomic prediction and breast cancer

08:30 - 09:30 Plenary lecture

Dr. W. Frayser Symmans, The University ofTexas MD Anderson Cancer Center. Houston, USA

14:00 - 14:15 Welcome / Overview
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

Moderator:

Dr. Víctor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA

14:15 - 15:00 Aggressive tumors of the skin appendages: Merkel cell carcinoma and other new entities
Dr. Víctor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA

15:00 - 15:45 Utility of molecular pathology techniques in the diagnosis of melanoma
Dr. José Luis Rodríguez-Peralto, Hospital Universitario 12 de Octubre. Madrid, Spain

15:45 - 16:00 Discussion
16:00 - 16:30 Coffee break

16:30 - 17:15 Inaugural lecture
Personalized cancer therapy and the future of health care

12:45 - 13:15 Therapeutic impact of molecular pathology in breast cancer: A clinical point of view

17:15 - 19:00 Session 2: Lung tumors
Moderator:

Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA

17:15 - 18:00 Molecular pathology of lung cancer - 2016
Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA

18:00 - 18:45 Application in Spain of the latest advances in lung cancer
Dr. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain

18:45 - 19:00 Discussion

Personalized cancer therapy: Can you MATCH this?

14:30 - 16:15 Session 5: Gynecologic tumors

10:15 - 10:45 What’s new in T-cell lymphomas and Hodgkin lymphoma

Moderator:

09:30 - 10:15 Diffuse large B-cell lymphoma
Dr. L. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA

14:30 - 15:00 Ovarian cancer, from molecular pathology to the 2014 WHO classification:
What you need to know
Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA

15:00 - 15:30 Integrating molecular pathology in histological typing and prediction of
recurrence in endometrial carcinoma
Dr. Xavier Matías-Guiu, Hospital Universitari Arnau de Vilanova. Lleida, Spain.
Hospital Universitari de Bellvitge. Barcelona, Spain

15:30 - 16:00 Deciphering intratumoral molecular heterogeneity in gynecological cancer
Dr. Gema Moreno-Bueno, MD Anderson Cancer Center Madrid, Spain

10:45 - 11:15 New insights into myeloid neoplasms
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA

10:15 - 11:30 Discussion
11:30 - 12:00 Coffee break

12:00 - 13:45 Session 9: Genitourinary tumors
Moderator:

Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA

12:45 - 13:30 The evolving landscape of urothelial bladder cancer
Dr. Francisco X. Real, Spanish National Cancer Research Center (CNIO). Madrid, Spain

16:15 - 18:00 Session 6: Sarcoma
Moderator:

Dr. Gemma Toledo Santana, MD Anderson Cancer Center Madrid, Spain

16:15 - 17:00 From genomics to practical clinical molecular diagnostics in sarcoma:
Where do we stand?
Dr. Alexander Lazar, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Enrique de Álava Casado, Hospital Virgen del Rocío. Seville, Spain

17:45 - 18:00 Discussion
18:00 - 18:30 Coffee break

13:30 - 13:45 Discussion
13:45 - 15:15 Lunch

15:15 - 17:00 Session 10: Central nervous system tumors
Moderator:

Dr. Stanley R. Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA

Dr. Gregory N. Fuller, The University of Texas MD Anderson Cancer Center. Houston, USA

16:00 - 16:45 Molecular genetics of gliomas
Moderator:

18:30 – 19:00
19:00 – 19:20

10:15 - 11:00 Molecular pathology of gastric cancer
Dr. Fátima Carneiro, Centro Hospitalar de São João. Porto, Portugal

11:00 - 11:15 Discussion
11:15 - 11:45 Coffee break

Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

FISH in diagnostic pathology: current applications and automatization
Dra. Blanca Espinet, Hospital del Mar. Barcelona, Spain

09:30 - 10:15 Tumor microenvironment and pancreatic cancer progression
Dr. Huamin Wang, The University of Texas MD Anderson Cancer Center. Houston, USA

Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain

15:15 - 16:00 Molecular classification of brain tumors comes of age: Introducing the 2016 World
Health Organization classification of tumors of the central nervous system
Dr. Bárbara Meléndez Asensio, Hospital Virgen de la Salud.Toledo, Spain

18:30 - 20:00 Session 7: Platform presentations
Moderator:

Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA

12:00 - 12:45 Renal cell carcinoma: A morphologic and molecular understanding of
aggressive and indolent tumors

16:00 - 16:15 Discussion

Dr. Stanley R. Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA

09:30 - 11:15 Session 3: Gastrointestinal tumors

Dr. L. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA

Moderator:

17:00 - 17:45 Molecular diagnostics and real life in sarcoma signout

Thursday, October 6th, 2016
08:30 - 09:30 Keynote lecture

09:30 - 11:30 Session 8: Hematolymphoid tumors

13:15 - 13:30 Discussion
13:30 - 14:30 Lunch

Dr. Joxel García, Executive Director, Cancer Control Platform, Moon Shots Operations.
The University of Texas MD Anderson Cancer Center. Houston, USA

Dr. Miguel Ángel Piris Pinilla, Hospital Universitario Marqués de Valdecilla. Santander, Spain

Dr. José Palacios Calvo, Hospital Universitario Ramón y Cajal. Madrid, Spain
Dr. Antonio González-Martín, MD Anderson Cancer Center Madrid, Spain

14:15 - 16:00 Session 1: Skin tumors

Lymphoproliferative diagnosis: integrated diagnosis paves the way to
precision medicine

12:15 - 12:45 New insights into the molecular pathology of lobular breast carcinoma

MEK and PIK3CB inhibitor combination as a promising therapeutical
approach for sarcomatoid mesothelioma
Dra. Miriam Marqués, Spanish National Cancer Research Center (CNIO). Madrid, Spain

19:20 – 19:40

Cancer of unknown primary origin in a patient with a presacral mass
and nerve sheath involvement
Dra. Tamara Ranchal, MD Anderson Cancer Center. Madrid, Spain

19:40 – 20:00

Circadian regulation of cancer stem cell markers in colorectal tumors
Dra. Inés Aroca, Instituto de Investigación Biosanitaria de Granada. Granada, Spain

16:45 - 17:00 Discussion
17:00 - 17:30 Coffee break

17:30 - 19:00 Session 11: Platform presentations
Moderator:

Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA

Case presentations / Platform presentations

19:00 - 19:30 Closing remarks
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain


2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program.pdf - page 1/2
2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program.pdf - page 2/2

Related documents


untitled pdf document
2826pathology meetingprogram
er1234
ming you cv 08 25 2016
er1086
programa actualizacion en el tratamiento de la leucemia aguda


Related keywords